Efficiency- and time-based cost fashions – like the only bluebird bio has proposed for LentiGlobin – are particularly more difficult to place into follow in the United States than in Europe, some executives mentioned at this week’s JPM convention.



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here